Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science
- PMID: 30214916
- PMCID: PMC6130840
- DOI: 10.1037/bar0000113
Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science
Abstract
Behavioral pharmacology is a branch of the experimental analysis of behavior that has had great influence in drug addiction research and policy. This paper provides an overview of recent behavioral pharmacology research in the field of tobacco regulatory science, which provides the scientific foundation for the Food and Drug Administration Center for Tobacco Products (FDA CTP) to set tobacco control policies. The rationale and aims of tobacco regulatory science are provided, including the types of preclinical operant behavioral models it deems important for assessing the abuse liability of tobacco products and their constituents. We then review literature relevant to key regulatory actions being considered by the FDA CTP, including regulations over nicotine and menthol content of cigarettes, and conclude with suggesting some directions for future research. The current era of tobacco regulatory science provides great opportunities for behavioral pharmacologists to address the leading cause of preventable death and disease worldwide.
Keywords: Behavioral Pharmacology; Nicotine; Policy; Regulatory Science; Tobacco.
Similar articles
-
Behavioral Economic Laboratory Research in Tobacco Regulatory Science.Tob Regul Sci. 2016 Oct;2(4):440-451. doi: 10.18001/TRS.2.4.13. Tob Regul Sci. 2016. PMID: 28580378 Free PMC article.
-
How Intravenous Nicotine Administration in Smokers Can Inform Tobacco Regulatory Science.Tob Regul Sci. 2016 Oct;2(4):452-463. doi: 10.18001/TRS.2.4.14. Epub 2016 Oct 1. Tob Regul Sci. 2016. PMID: 29082299 Free PMC article.
-
Experimental analysis of behavior and tobacco regulatory research on nicotine reduction.J Exp Anal Behav. 2018 Jul;110(1):1-10. doi: 10.1002/jeab.439. Epub 2018 Jun 4. J Exp Anal Behav. 2018. PMID: 29869329
-
Basic Science and Public Policy: Informed Regulation for Nicotine and Tobacco Products.Nicotine Tob Res. 2018 Jun 7;20(7):789-799. doi: 10.1093/ntr/ntx175. Nicotine Tob Res. 2018. PMID: 29065200 Free PMC article. Review.
-
Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations.Nicotine Tob Res. 2022 Feb 14;24(3):295-305. doi: 10.1093/ntr/ntab183. Nicotine Tob Res. 2022. PMID: 34498698 Review.
Cited by
-
Stimulus functions of nicotine.Adv Pharmacol. 2022;93:133-170. doi: 10.1016/bs.apha.2021.11.001. Epub 2022 Jan 12. Adv Pharmacol. 2022. PMID: 35341565 Free PMC article.
-
The reinforcement threshold and elasticity of demand for nicotine in an adolescent rat model of depression.Drug Alcohol Depend. 2021 Feb 1;219:108433. doi: 10.1016/j.drugalcdep.2020.108433. Epub 2020 Dec 3. Drug Alcohol Depend. 2021. PMID: 33310485 Free PMC article.
-
Effects of volatile organic compounds found in cigarette smoke on intracranial self-stimulation in rats.Drug Alcohol Depend. 2025 Jun 1;271:112633. doi: 10.1016/j.drugalcdep.2025.112633. Epub 2025 Feb 26. Drug Alcohol Depend. 2025. PMID: 40117780
-
Multifactorial Etiology of Adolescent Nicotine Addiction: A Review of the Neurobiology of Nicotine Addiction and Its Implications for Smoking Cessation Pharmacotherapy.Front Public Health. 2021 Jul 5;9:664748. doi: 10.3389/fpubh.2021.664748. eCollection 2021. Front Public Health. 2021. PMID: 34291026 Free PMC article. Review.
-
Non-nicotine constituents in e-cigarette aerosol extract attenuate nicotine's aversive effects in adolescent rats.Drug Alcohol Depend. 2019 Oct 1;203:51-60. doi: 10.1016/j.drugalcdep.2019.05.023. Epub 2019 Aug 1. Drug Alcohol Depend. 2019. PMID: 31404849 Free PMC article.
References
-
- Abrams DB, Herzog TA, Emmons KM, Linnan L. Stages of change versus addiction: a replication and extension. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco. 2000;2(3):223–229. - PubMed
-
- Adriani W, Laviola G. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behavioural Pharmacology. 2004;15(5–6):341–352. - PubMed
-
- Adriani W, Macrì S, Pacifici R, Laviola G. Peculiar vulnerability to nicotine oral self-administration in mice during early adolescence. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2002;27(2):212–224. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources